Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

904.95

13.40 (1.50%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Cadila’s arm gets tentative approval from USFDA for Pimavanserin Capsules

>>

Zydus Cadila gets tentative approval from USFDA for Pimavanserin tablets

>>

Cadila Healthcare informs about loss of share certificate

>>

Zydus Cadila gets orphan drug designation from USFDA for antimalarial compound

>>

Cadila Healthcare trades higher on the BSE

>>

Zydus Cadila gets permission to initiate Phase II (a) clinical study of ‘ZYIL1’

>>

Cadila Healthcare informs about press release

>>

Zydus Cadila’s arm gets tentative approval from USFDA to market Cariprazine Capsules

>>

Cadila Healthcare informs about press release

>>

Cadila Healthcare informs about loss of share certificate

<< < 70 71 72 ...168 > >>